These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 12867222

  • 1. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
    Volpe M, Junren Z, Maxwell T, Rodriguez A, Gamboa R, Gomez-Fernandez P, Ortega-Gonzalez G, Matadamas N, Rodriguez F, Dass B, Kyle C, Clarysse L, Bryce A, Moreno-Heredia E, Germano G, Gilles L, Smith RD, Sanderson JE, CDSP-944 Study Group.
    Clin Ther; 2003 May; 25(5):1469-89. PubMed ID: 12867222
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
    Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J.
    Clin Ther; 1996 May; 18(4):608-25. PubMed ID: 8879890
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 5. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kwan J, Yoon MH, Lee KJ, Lim DS.
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [Abstract] [Full Text] [Related]

  • 6. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
    Manolis AJ, Grossman E, Jelakovic B, Jacovides A, Bernhardi DC, Cabrera WJ, Watanabe LA, Barragan J, Matadamas N, Mendiola A, Woo KS, Zhu JR, Mejia AD, Bunt T, Dumortier T, Smith RD.
    Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
    Payeras AC, Sladek K, Lembo G, Alberici M.
    Clin Drug Investig; 2007 Oct; 27(9):623-32. PubMed ID: 17705571
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY, Ahn T, Bae JH, Lim DS, Lee SU, Kim YK, Hyon MS, Kim WH, Han KR, Park HK.
    Clin Ther; 2014 Oct 01; 36(10):1402-11. PubMed ID: 25146365
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
    Kim KI, Shin MS, Ihm SH, Youn HJ, Sung KC, Chae SC, Nam CW, Seo HS, Park SM, Rhee MY, Kim MH, Cha KS, Kim YJ, Kim JJ, Chun KJ, Yoo BS, Park S, Shin ES, Kim DS, Il Kim D, Kim KH, Joo SJ, Jeong JO, Shin J, Kim CH.
    Clin Ther; 2016 Oct 01; 38(10):2159-2170. PubMed ID: 27502326
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
    Flack JM, Saunders E, Gradman A, Kraus WE, Lester FM, Pratt JH, Alderman M, Green S, Vargas R, Espenshade M, Ceesay P, Alexander J, Goldberg A, Study Group for Losartan in African Americans with Hypertension.
    Clin Ther; 2001 Aug 01; 23(8):1193-208. PubMed ID: 11558858
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
    Weir MR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM.
    Clin Ther; 1996 Aug 01; 18(3):411-28. PubMed ID: 8829017
    [Abstract] [Full Text] [Related]

  • 14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 01; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
    Hong SJ, Jeong HS, Han SH, Chang KY, Hong BK, Lee BK, Chae SC, Kim WS, Park CG, Heo JH, Lee SU, Kim YD, Kim KS, Choi JH, Kang HJ, Kim JJ, Kang SM, Choi YJ, Shin JH, Chun KJ, Shin DG, Park SH, Kwan J, Choi YJ, Jeong MH, Chae JK, Kim DW, Cho JR, Han KR, Won KH, Park SH, Lee SK, Kim SH, Jung J, Kim CH.
    Clin Ther; 2017 Oct 01; 39(10):2049-2060. PubMed ID: 28939406
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A, Oigman W, Lepe L, Cifkova R, Karpov YA, Harron DW.
    Acta Cardiol; 1997 Oct 01; 52(6):495-506. PubMed ID: 9542575
    [Abstract] [Full Text] [Related]

  • 17. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF, Duprez D, Purkayastha D, Samuel R, Ferdinand KC.
    J Clin Hypertens (Greenwich); 2011 Aug 01; 13(8):588-97. PubMed ID: 21806769
    [Abstract] [Full Text] [Related]

  • 18. A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and losartan 50 mg/hydrochlorothiazide 12.5 mg in the treatment of moderate-to-severe essential hypertension.
    Gradman AH, Brady WE, Gazdick LP, Lyle P, Zeldin RK.
    Clin Ther; 2002 Jul 01; 24(7):1049-61. PubMed ID: 12182251
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.
    Clin Ther; 2009 May 01; 31(5):988-98. PubMed ID: 19539099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.